Robotic laparoscopic radical prostatectomy for biopsy gleason 8 to 10: Prediction of favorable pathologic outcome with preoperative parameters

Journal of Endourology

Volumn 22, Issue 7, 2008, Pages 1477-1481

  Shikanov, Sergey A ^a   Thong, Alan ^a   Gofrit, Ofer N ^b   Zagaja, Gregory P ^a   Steinberg, Gary D ^a   Shalhav, Arieh L ^a   Zorn, Kevin C ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; GLEASON SCORE; HISTOPATHOLOGY; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; LAPAROSCOPIC SURGERY; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RECURRENT DISEASE; ROBOTICS; TREATMENT OUTCOME;

BIOPSY; HUMANS; LAPAROSCOPY; MALE; MIDDLE AGED; NEOPLASM STAGING; PREOPERATIVE CARE; PROSTATECTOMY; PROSTATIC NEOPLASMS; ROBOTICS; TREATMENT OUTCOME;

EID: 50649093065     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2008.0091     Document Type: Article

References (20)

1. Lau WK, Bergstralh EJ, Blute ML, Slezak JM, Zincke H. Radical prostatectomy for pathological Gleason 8 or greater prostate cancer: Influence of concomitant pathological variables. J Urol 2002;167:117-122.
2. Murphy GP, Natarajan N, Pontes JE, Schmitz RL. Smart CR, Schmidt JD, Mettlin C. The national survey of prostate cancer in the United States by the American College of Surgeons. J Urol 1982;127:928-934.
3. Rioux-Leclercq NC, Chan DY, Epstein JI. Prediction of outcome after radical prostatectomy in men with organ-confined Gleason score 8 to 10 adenocarcinoma. Urology 2002;60:666-669.
4. Manoharan M, Bird VG, Kim SS, Civantos F, Soloway MS. Outcome after radical prostatectomy with a pretreatment prostate biopsy Gleason score of >/=8. BJU Int 2003;92:539-544.
5. Makarov DV, Trock BJ, Humphreys EB, Mangold LA, Walsh PC, Epstein JI, Partin AW. Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005. Urology 2007;69:1095-1101.
6. Kattan MW, Wheeler TM, Scardino PT. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol 1999;17:1499-1507.
7. D'Amico AV, Schultz D, Silver B, Henry L, Hurwitz M, Kaplan I, Beard CJ, Renshaw AA. The clinical utility of the percent of positive prostate biopsies in predicting biochemical outcome following external-beam radiation therapy for patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 2001;49:679-684.
8. Freedland SJ, Aronson WJ, Terris MK, Kane CJ, Amling CL, Dorey F, Presti JC Jr; The SEARCH Database Study Group. Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: Results from SEARCH database. J Urol 2003;169:2136-2141.
9. Freedland SJ, Terris MK, Csathy GS, Kane CJ, Amling CL, Presti JC Jr, Dorey F, Aronson WJ; Search Database Study Group. Preoperative model for predicting prostate specific antigen recurrence after radical prostatectomy using percent of biopsy tissue with cancer, biopsy Gleason grade and serum prostate specific antigen. J Urol 2004;171:2215-2220.
10. Freedland SJ, Csathy GS, Dorey F, Aronson WJ. Clinical utility of percent prostate needle biopsy tissue with cancer cutpoints to risk stratify patients before radical prostatectomy. Urology 2002;60:84-88.
11. Grossfeld GD, Chang JJ, Broering JM, Li YP, Lubeck DP, Flanders SC, Carroll PR. Under staging and under grading in a contemporary series of patients undergoing radical prostatectomy: Results from the Cancer of the Prostate Strategic Urologic Research Endeavor database. J Urol 2001;165:851-856.
12. Poulos CK, Daggy JK, Cheng L. Prostate needle biopsies: Multiple variables are predictive of final tumor volume in radical prostatectomy specimens. Cancer 2004;101:527-532.
13. Ficarra V, Cavalleri S, Novara G, Aragona M, Artibani W. Evidence from robot-assisted laparoscopic radical prostatectomy: A systematic review. Eur Urol 2007;51:45-56.
14. Badani KK, Kaul S, Menon M. Evolution of robotic radical prostatectomy: Assessment after 2766 procedures. Cancer 2007;110:1951-1958.
15. Zorn KC, Gofrit ON, Orvieto MA, Mikhail AA, Zagaja GP, Shalhav AL. Robotic-assisted laparoscopic prostatectomy: Functional and pathologic outcomes with interfascial nerve preservation. Eur Urol 2007;51:755-763.
16. Amin MB, Grignon D, Bostwick D, Reuter V, Troncoso P, Ayala AG. Recommendations for the reporting of resected prostate carcinomas. Association of Directors of Anatomic and Surgical Pathology. Am J Clin Pathol 1996;105:667-670.
17. Hurwitz MD, Schultz D, Richie JP, Wein AJ, Whittington R, Malkowicz SB, D'Amico AV. Radical prostatectomy for high-grade prostate cancer. Urology 2006;68:367-370.
18. Grossfeld GD, Latini DM, Lubeck DP, Mehta SS, Carroll PR. Predicting recurrence after radical prostatectomy for patients with high risk prostate cancer. J Urol 2003;169:157-163.
19. Ohori M, Goad JR, Wheeler TM, Eastham JA, Thompson TC, Scardino PT. Can radical prostatectomy alter the progression of poorly differentiated prostate cancer? J Urol 1994;152:1843-1849.
20. Grossfeld GD, Latini DM, Lubeck DP, Broering JM, Li YP, Mehta SS, Carroll PR. Predicting disease recurrence in intermediate and high-risk patients undergoing radical prostatectomy using percent positive biopsies: Results from CaPSURE. Urology 2002;59:560-565.